Forcing Kidney Cells to Divide Reveals a Hard Limit on Glomerular Growth

Podocytes, the highly specialized epithelial cells that wrap around the kidney’s filtering capillaries, are widely regarded as the Achilles heel of the glomerulus. Once they mature during nephron development, they essentially stop dividing, and when disease or aging whittles their numbers down, the remaining cells cannot reliably replace them. This limited proliferative capacity is thought to underpin the irreversible progression of many chronic kidney diseases. A long-standing question in nephrology has therefore been deceptively simple: if you could just make more podocytes, would the glomerulus grow bigger and function better? A new study in Physiological Reports answers with a careful, technically rigorous no, at least when the extra podocytes are produced after a critical developmental window has already closed.

The research team, led by Taiji Matsusaka of Tokai University School of Medicine, built a transgenic mouse platform designed to force podocytes back into the cell cycle on demand. The system exploits the Tet-On inducible expression technology, in which a tetracycline-responsive element drives transgene expression only when the antibiotic doxycycline is present. The authors microinjected a construct containing the Simian virus 40 large T antigen (SV40T) coding sequence, together with a lacZ reporter, into fertilized mouse eggs and established transgenic lines. SV40T is a viral oncoprotein best known for promoting cell-cycle entry by binding and functionally inactivating two key tumor suppressors, p53 and the retinoblastoma protein (Rb). Because it can push otherwise quiescent cells past the G1 restriction point, it is a standard tool for immortalizing podocytes in culture, making it a logical choice for attempts to stimulate division in vivo.

The transgenic line was crossed with Nphs2-rtTA mice, in which the reverse tetracycline transactivator is expressed specifically in podocytes under the podocin promoter. In double-transgenic offspring, doxycycline in the drinking water therefore triggered SV40T production exclusively in podocytes. The specificity was confirmed by immunostaining: after four to fourteen days of treatment, roughly twenty to thirty percent of podocytes per glomerular section expressed the viral antigen, while untreated animals and single-transgenic controls showed nothing. Critically, the forced cells did more than merely turn on the transgene. Between 9.3 and 17.7 percent of podocytes became positive for Ki67, a marker spanning late G1 through mitosis, incorporated bromodeoxyuridine to indicate DNA synthesis, expressed Aurora kinase B, and occasionally displayed mitotic figures. At the same time, p57Kip2, a cyclin-dependent kinase inhibitor that typifies the mature podocyte state, was downregulated in the SV40T-positive cells. The quiescent filter cells had, by every molecular criterion, re-entered the cell cycle.

In adult mice, however, this proliferative push came at a steep price. Cytokinesis frequently failed, leaving podocytes multinucleated or bearing enlarged nuclei. Within the first week of doxycycline exposure, kidney morphology was largely preserved apart from microvillous transformation of the podocytes, but the urinary albumin-to-creatinine ratio climbed dramatically, from control values near 0.02 to 15.76 by day seven and 40.27 by day fourteen. By two weeks, the slit diaphragm proteins nephrin and podocin were reduced and the injury marker desmin appeared in glomerular segments. After four or more weeks of continuous induction, every treated mouse developed focal segmental glomerulosclerosis of the usual type, complete with secondary tubulointerstitial damage in the most severely affected kidneys. Intriguingly, the damaged podocytes no longer expressed SV40T, apparently because podocyte injury extinguishes Nphs2-driven rtTA expression, an automatic brake on the system. Repeated short treatment cycles combined with the angiotensin receptor blocker losartan produced only a modest, marginal increase in podocyte counts, confirming that adult podocytes resist expansion even under carefully titrated conditions.

That failure redirected the strategy toward embryogenesis, a period when podocyte progenitors are naturally proliferative and the glomerulus has not yet been exposed to high filtration pressures. Pregnant dams carrying SV40T/rtTA embryos received doxycycline from embryonic day 14.5 until birth. The team also incorporated a third genetic element: Bcl2 knockout alleles. Homozygous Bcl2-deficient mice are a classical model of oligomeganephronia, a condition in which apoptosis of undifferentiated mesenchymal cells between embryonic days 13 and 16 drastically reduces nephron number, forcing the surviving glomeruli to enlarge compensatorily. This provided a natural test bed for whether extra podocytes could augment, or even drive, glomerular hypertrophy under strong physiological pressure.

The results at birth were striking. Newborn double-transgenic pups, on either Bcl2 background, carried markedly more podocytes than their littermate controls, with nearly all inner-cortical podocytes expressing SV40T and most of those positive for Ki67. On average, the number of WT1-positive podocytes per glomerulus rose by 54 percent. Importantly, these surplus cells had not simply dedifferentiated into a pathological mass: they retained robust expression of podocin, WT1, and podocalyxin, the molecular signature of committed podocytes, and they did not resemble the crescents seen in collapsing glomerulopathies. Yet the glomerular tuft area, measured by painstaking morphometry of all non-tangential glomeruli across entire kidney cross-sections, was not significantly larger than in controls. Even individual glomeruli loaded with excessive podocytes never exceeded the size of ordinary control glomeruli. The correlation between podocyte number and glomerular volume, so reliable in normal growth, had been decisively broken from the other direction.

Rather than integrating neatly into the filtration barrier, the extra podocytes misbehaved structurally. They formed multilayers instead of the normal monolayer, detached from the glomerular basement membrane, and scattered into Bowman’s space or even into tubular lumens. Double immunostaining showed that most cells remained mononuclear, with WT1-positive nuclei enclosed by podocalyxin, arguing against rampant failed division. Markers of DNA damage (gammaH2AX) and apoptosis (cleaved lamin A) appeared in only a small fraction of cells, averaging 0.26 and 0.39 per glomerulus respectively. The authors interpret this pattern as evidence that adhesive failure during mitotic rounding, rather than programmed cell death, is the dominant mechanism of loss. During mitosis, epithelial cells normally round up and transiently weaken integrin-mediated adhesion before reattaching; podocytes, with their intricate foot-process architecture and dependence on precise attachment to the basement membrane, appear exceptionally vulnerable to this structural upheaval.

The Bcl2-deficient experiments sharpened the conclusion. All Bcl2 knockout mice, regardless of transgene status, showed severe renal hypoplasia with few, enlarged glomeruli. In SV40T-expressing Bcl2-deficient pups, podocyte numbers rose as in the wild-type background, but many cells again detached from the glomerular basement membrane, and the tuft area was actually significantly smaller than in Bcl2-deficient littermates lacking the transgene. In other words, even when compensatory hypertrophy should have been pushing glomeruli to expand, the surplus, poorly anchored podocytes appeared to exert a squeezing effect that constrained tuft growth. Structural integration, not cell supply, proved to be the limiting factor.

Postnatal follow-up sealed the outcome. Among 26 pups analyzed at postnatal day 7, the previously excessive podocyte populations had vanished: podocyte number and tuft area in transgenic animals were indistinguishable from controls, and glomeruli containing more than thirty podocytes, common at birth, were no longer observed. The authors propose several non-exclusive explanations for this elimination. Podocytes may lack the stringent planar-division orientation control that keeps renal tubular epithelia in a monolayer, dooming misplaced daughters. Alternatively, a quality-control mechanism known as cell competition, in which fitter neighbors actively expunge less fit cells, may recognize SV40T-induced podocytes as losers and remove them, effectively imposing an occupancy-management system on the glomerular tuft.

The broader implication is a reframing of how glomerular size is set. Because the Nphs2 promoter only activates once podocytes have passed the S-shaped body stage, the study could not boost progenitor pools at earlier stages, and the authors conclude that glomerular size is likely determined at or before that point in nephrogenesis. Adding podocytes afterward, even during the permissive embryonic environment, cannot override the architectural constraints of the developing tuft. For regenerative medicine, the message is sobering but precise: future strategies to expand the podocyte population must either target earlier progenitor stages or solve the biophysical problems of division orientation and cell-matrix adhesion so that new cells can stably integrate into the filter. Simply forcing mature or nearly mature podocytes to cycle, whether by viral oncoproteins or other means, produces cells that the glomerulus cannot accommodate and ultimately discards.

Subject of Research: The effect of experimentally induced podocyte proliferation on glomerular size in mice

Article Title: Increase in podocyte number induced by SV40T antigen during the fetal stage does not expand glomerular size in mice

Article References: Matsusaka, T., Ichimura, K., Miyaki, T., & Koizumi, M. (2026). Increase in podocyte number induced by SV40T antigen during the fetal stage does not expand glomerular size in mice. Physiological Reports, 14(19), Article e71114. https://doi.org/10.14814/phy2.71114

Image Credits: AI Generated

DOI: 10.14814/phy2.71114

Keywords: podocytes, glomerulus, SV40 large T antigen, kidney development, Tet-On system, focal segmental glomerulosclerosis, Bcl2 deficiency, oligomeganephronia, mitotic catastrophe, cell competition, glomerular basement membrane, chronic kidney disease